Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CAVA, SRRK, LXRX, CYTK, APLS, and represent 64.95% of Artal Group's stock portfolio.
- Added to shares of these 10 stocks: ARGX (+$44M), SRRK (+$41M), ARWR (+$37M), Korro Bio (+$20M), KYMR (+$19M), PRTA (+$18M), HARP (+$14M), SLN (+$8.7M), Lexeo Therapeutics (+$8.1M), CNTA (+$8.1M).
- Started 15 new stock positions in CNTA, ARGX, PRTA, CBAY, LLY, Korro Bio, DLO, CFLT, GPCR, CWAN. MDB, RELY, Lexeo Therapeutics, Tourmaline Bio, PDD.
- Reduced shares in these 10 stocks: MRTX (-$131M), CERE (-$69M), CYTK (-$25M), , RVMD (-$24M), ALPN (-$22M), APLS (-$15M), VTYX (-$14M), RYZB (-$12M), GERN (-$12M).
- Sold out of its positions in ADAP, ALNY, AUPH, RNA, BEAM, CRWD, Cyclerion Therapeutics, DAWN, GERN, IMAB. IMGN, NTLA, KA, NBTX, NFLX, PLRX, RYZB, SQZB, SQ, Talaris Therapeutics, VTYX, VERV, VRDN, LVTX.
- Artal Group was a net seller of stock by $-179M.
- Artal Group has $3.0B in assets under management (AUM), dropping by 28.97%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Artal Group
Artal Group holds 92 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Cava Group Ord (CAVA) | 45.7 | $1.4B | 32M | 42.98 |
|
|
Scholar Rock Hldg Corp (SRRK) | 7.0 | $212M | +24% | 11M | 18.80 |
|
Lexicon Pharmaceuticals Com New (LXRX) | 6.0 | $180M | 118M | 1.53 |
|
|
Cytokinetics Com New (CYTK) | 3.4 | $101M | -20% | 1.2M | 83.49 |
|
Apellis Pharmaceuticals (APLS) | 2.8 | $85M | -14% | 1.4M | 59.86 |
|
Beigene Sponsored Adr (BGNE) | 2.4 | $73M | 405k | 180.36 |
|
|
Kymera Therapeutics (KYMR) | 2.1 | $64M | +40% | 2.5M | 25.46 |
|
Amicus Therapeutics (FOLD) | 2.1 | $64M | 4.5M | 14.19 |
|
|
Morphic Hldg (MORF) | 2.1 | $62M | 2.1M | 28.88 |
|
|
Springworks Therapeutics (SWTX) | 2.0 | $59M | -11% | 1.6M | 36.50 |
|
Silence Therapeutics Ads (SLN) | 1.7 | $52M | +20% | 3.0M | 17.37 |
|
Revolution Medicines (RVMD) | 1.6 | $49M | -32% | 1.7M | 28.68 |
|
Argenx Se Sponsored Adr (ARGX) | 1.5 | $44M | NEW | 116k | 380.43 |
|
Neumora Therapeutics (NMRA) | 1.4 | $44M | -8% | 2.6M | 17.05 |
|
Arrowhead Pharmaceuticals (ARWR) | 1.2 | $38M | +22478% | 1.2M | 30.60 |
|
Mirati Therapeutics Call Option (MRTX) | 1.0 | $29M | -81% | 500k | 58.75 |
|
Igm Biosciences (IGMS) | 0.9 | $26M | +22% | 3.1M | 8.31 |
|
Kura Oncology (KURA) | 0.8 | $25M | -12% | 1.8M | 14.38 |
|
Acelyrin (SLRN) | 0.8 | $23M | +22% | 3.0M | 7.46 |
|
Glycomimetics (GLYC) | 0.7 | $20M | 8.6M | 2.36 |
|
|
Korro Bio | 0.7 | $20M | NEW | 419k | 47.93 |
|
Syros Pharmaceuticals Com New (SYRS) | 0.6 | $20M | +69% | 2.5M | 7.79 |
|
Prothena Corp SHS (PRTA) | 0.6 | $18M | NEW | 501k | 36.34 |
|
Denali Therapeutics (DNLI) | 0.6 | $17M | 803k | 21.46 |
|
|
Dyne Therapeutics (DYN) | 0.5 | $16M | +49% | 1.2M | 13.30 |
|
Wave Life Sciences SHS (WVE) | 0.5 | $15M | +50% | 3.0M | 5.05 |
|
Sea Sponsored Ads (SE) | 0.5 | $15M | -6% | 372k | 40.50 |
|
Harpoon Therapeutics Com New (HARP) | 0.5 | $15M | +1204% | 1.3M | 11.37 |
|
Agenus Com New (AGEN) | 0.4 | $13M | 16M | 0.83 |
|
|
Natera (NTRA) | 0.4 | $13M | 200k | 62.64 |
|
|
Roivant Sciences SHS (ROIV) | 0.4 | $11M | 1.0M | 11.23 |
|
|
Gossamer Bio (GOSS) | 0.4 | $11M | +91% | 12M | 0.91 |
|
Schrodinger (SDGR) | 0.4 | $11M | -40% | 300k | 35.80 |
|
Erasca (ERAS) | 0.3 | $10M | 4.7M | 2.13 |
|
|
Fusion Pharmaceuticals (FUSN) | 0.3 | $9.7M | -41% | 1.0M | 9.61 |
|
Seer Com Cl A (SEER) | 0.3 | $9.2M | 4.8M | 1.94 |
|
|
Lexeo Therapeutics | 0.3 | $8.1M | NEW | 603k | 13.42 |
|
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $8.1M | NEW | 1.0M | 7.96 |
|
Ovid Therapeutics (OVID) | 0.3 | $8.1M | 2.5M | 3.22 |
|
|
Cymabay Therapeutics (CBAY) | 0.2 | $7.2M | NEW | 304k | 23.62 |
|
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.2 | $7.1M | -33% | 68k | 104.00 |
|
Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $6.5M | 3.7M | 1.77 |
|
|
Selecta Biosciences (RNAC) | 0.2 | $6.3M | 9.1M | 0.69 |
|
|
Vigil Neuroscience (VIGL) | 0.2 | $6.1M | -5% | 1.8M | 3.38 |
|
Black Diamond Therapeutics (BDTX) | 0.2 | $5.8M | 2.0M | 2.81 |
|
|
Solid Biosciences Com New (SLDB) | 0.2 | $5.6M | 909k | 6.14 |
|
|
Vor Biopharma (VOR) | 0.2 | $5.3M | -12% | 2.3M | 2.25 |
|
Repare Therapeutics Ord (RPTX) | 0.2 | $5.1M | 700k | 7.30 |
|
|
Sagimet Biosciences Com Ser A (SGMT) | 0.2 | $5.0M | 925k | 5.42 |
|
|
Pdd Holdings Sponsored Ads (PDD) | 0.2 | $4.8M | NEW | 33k | 146.31 |
|
Foghorn Therapeutics (FHTX) | 0.2 | $4.6M | -58% | 721k | 6.45 |
|
Generation Bio (GBIO) | 0.2 | $4.6M | 2.8M | 1.65 |
|
|
Hookipa Pharma Inc equity (HOOK) | 0.2 | $4.6M | 5.7M | 0.81 |
|
|
Allovir (ALVR) | 0.1 | $4.5M | 6.6M | 0.68 |
|
|
Iteos Therapeutics (ITOS) | 0.1 | $4.4M | 400k | 10.95 |
|
|
Replimune Group (REPL) | 0.1 | $4.2M | 500k | 8.43 |
|
|
Ke Hldgs Sponsored Ads (BEKE) | 0.1 | $4.1M | -9% | 250k | 16.21 |
|
Omega Therapeutics (OMGA) | 0.1 | $4.0M | -47% | 1.3M | 3.01 |
|
Paypal Holdings (PYPL) | 0.1 | $3.9M | +70% | 63k | 61.40 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $3.5M | NEW | 87k | 40.76 |
|
Tourmaline Bio | 0.1 | $2.4M | NEW | 91k | 26.19 |
|
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $2.0M | 2.3M | 0.89 |
|
|
Ikena Oncology (IKNA) | 0.1 | $2.0M | -45% | 1000k | 1.97 |
|
Adagene Ads (ADAG) | 0.1 | $1.9M | 1.0M | 1.93 |
|
|
Amazon (AMZN) | 0.1 | $1.8M | 12k | 151.92 |
|
|
Kanzhun Sponsored Ads (BZ) | 0.1 | $1.7M | -54% | 100k | 16.61 |
|
Curis (CRIS) | 0.0 | $1.3M | 105k | 12.75 |
|
|
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.3M | 111k | 11.44 |
|
|
Alphabet Cap Stk Cl A (GOOGL) | 0.0 | $1.1M | +41% | 7.8k | 139.74 |
|
Kronos Bio (KRON) | 0.0 | $1.1M | -45% | 843k | 1.25 |
|
Alpine Immune Sciences (ALPN) | 0.0 | $967k | -95% | 51k | 19.05 |
|
Microsoft Corporation (MSFT) | 0.0 | $940k | -54% | 2.5k | 376.00 |
|
Datadog Cl A Com (DDOG) | 0.0 | $910k | -34% | 7.5k | 121.33 |
|
Intapp (INTA) | 0.0 | $665k | +75% | 18k | 38.00 |
|
Procore Technologies (PCOR) | 0.0 | $658k | +111% | 9.5k | 69.26 |
|
Visa Com Cl A (V) | 0.0 | $651k | -66% | 2.5k | 260.40 |
|
23andme Holding Class A Com (ME) | 0.0 | $604k | 661k | 0.91 |
|
|
Caribou Biosciences (CRBU) | 0.0 | $604k | 105k | 5.73 |
|
|
Eli Lilly & Co. (LLY) | 0.0 | $583k | NEW | 1.0k | 583.00 |
|
Pegasystems (PEGA) | 0.0 | $562k | +53% | 12k | 48.87 |
|
Remitly Global (RELY) | 0.0 | $486k | NEW | 25k | 19.44 |
|
Cyclerion Therapeutics (CYCN) | 0.0 | $466k | 139k | 3.35 |
|
|
Confluent Class A Com (CFLT) | 0.0 | $445k | NEW | 19k | 23.42 |
|
Mongodb Cl A (MDB) | 0.0 | $409k | NEW | 1.0k | 409.00 |
|
Clearwater Analytics Hldgs I Cl A (CWAN) | 0.0 | $401k | NEW | 20k | 20.05 |
|
Advanced Micro Devices (AMD) | 0.0 | $369k | -58% | 2.5k | 147.60 |
|
Dlocal Class A Com (DLO) | 0.0 | $354k | NEW | 20k | 17.70 |
|
Xilio Therapeutics (XLO) | 0.0 | $248k | 450k | 0.55 |
|
|
Hippo Hldgs Com New (HIPO) | 0.0 | $219k | 24k | 9.12 |
|
|
Cerevel Therapeutics Hldng I (CERE) | 0.0 | $214k | -99% | 5.0k | 42.45 |
|
Senti Biosciences Ord (SNTI) | 0.0 | $37k | 56k | 0.67 |
|
|
Mink Therapeutics (INKT) | 0.0 | $2.0k | 1.9k | 1.04 |
|
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2023 Q4 filed Feb. 9, 2024
- Artal Group 2023 Q3 filed Nov. 13, 2023
- Artal Group 2023 Q2 filed Aug. 11, 2023
- Artal Group 2023 Q1 filed May 12, 2023
- Artal Group 2022 Q4 filed Feb. 13, 2023
- Artal Group 2022 Q3 filed Nov. 14, 2022
- Artal Group 2022 Q2 filed Aug. 11, 2022
- Artal Group 2022 Q1 filed May 12, 2022
- Artal Group 2021 Q4 filed Feb. 11, 2022
- Artal Group 2021 Q3 filed Nov. 12, 2021
- Artal Group 2021 Q2 filed Aug. 13, 2021
- Artal Group 2021 Q1 filed May 14, 2021
- Artal Group 2020 Q4 filed Feb. 11, 2021
- Artal Group 2020 Q3 filed Nov. 13, 2020
- Artal Group 2020 Q2 filed Aug. 14, 2020
- Artal Group 2020 Q1 filed May 14, 2020